Rosenblum Silverman Sutton’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-9,665
Closed -$579K 66
2016
Q3
$579K Sell
9,665
-1,400
-13% -$80.6K 0.27% 56
2016
Q2
$637K Buy
+11,065
New +$739K 0.31% 52
2015
Q4
$705K Sell
11,065
-1,150
-9% -$74.2K 0.32% 54
2015
Q3
$818K Sell
12,215
-950
-7% -$67.7K 0.39% 53
2015
Q2
$888K Buy
+13,165
New +$929K 0.36% 55
2014
Q4
$779K Sell
11,595
-600
-5% -$39.4K 0.34% 54
2014
Q3
$841K Buy
12,195
+8,380
+220% +$656K 0.38% 55
2014
Q2
$313K Sell
3,815
-700
-16% -$47.4K 0.15% 63
2014
Q1
$306K Buy
4,515
+850
+23% +$63.2K 0.15% 67
2013
Q4
$261K Buy
3,665
+165
+5% +$12.8K 0.12% 70
2013
Q3
$267K Buy
+3,500
New +$242K 0.14% 65

Other funds holding PRLB

Rosenblum Silverman Sutton's PRLB Position: Q4 2016 in Review

Rosenblum Silverman Sutton sold out of Protolabs (PRLB) in Q4 2016, closing a stake of 9,665 shares — an estimated $579K sold.

Rosenblum Silverman Sutton first reported a position in PRLB in Q3 2013 and held it in 11 quarters. The position peaked at $888K in Q2 2015. 196 funds tracked by Wall St. Rank hold PRLB as of Q4 2016.

  • Rosenblum Silverman Sutton reported no remaining Protolabs position as of Q4 2016 after selling out during the quarter.
  • Rosenblum Silverman Sutton sold 9,665 Protolabs shares in Q4 2016, an estimated $579K.
  • Rosenblum Silverman Sutton first reported a position in Protolabs in Q3 2013 and held it in 11 quarters.
  • Rosenblum Silverman Sutton's Protolabs position peaked at $888K in Q2 2015.
  • 196 funds tracked by Wall St. Rank held Protolabs as of Q4 2016.

Based on Rosenblum Silverman Sutton's 13F filing for Q4 2016, filed 14 Feb 2017.